Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hayat

Showing results (91-100 of 299) with videos related to

Pageof 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's diseaseM Tubiana, M Henry-Amar, M V Burgers, et al.
Nouvelle Revue Francaise D'Hematologie; Blood Cells|January 1, 1977
[Treatment of clinical stages I and II of Hodgkin's disease]M Tubiana, G Mathé, M Hayat, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
The contribution of clinical trials to the treatment of patients with early stages of Hodgkin's diseaseM Tubiana, J M Cosset, P Carde, et al.
Blood|August 15, 1994
Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?P Y Dietrich, M Henry-Amar, J M Cosset, et al.
Bulletin Du Cancer|January 1, 1989
[Intracranial localization of Hodgkin's disease. Apropos of 2 cases]J P Constans, A Castresana, J F Meder, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1985
Erythropoietic recovery in human after extended field radiotherapy. Ferrokinetic studies of patients treated by radiotherapy followed by autologous bone marrow transplantation and of patients treated by moderate doses (20 Gy) of radiotherapyC Parmentier, N Morardet, M Schlumberger, et al.
Annales De Medecine Interne|February 1, 1975
[10 years of immunotherapy of leukemia and cancers]G Mathe, L Schwarzenberg, J L Amiel, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|November 7, 1977
[Oncostatic activity of extracts from Alangium vitiense on murine lymphoid neoplasms]M Hayat, G Mathé, E Chenu, et al.
Cancer Research|May 1, 1978
Oncostatic effects of Alangium vitiense extracts (ICIG-EORTC 1131, 1186 and 1207) on lymphoid murine tumorsG Mathé, M Hayat, E Chenu, et al.
Bone Marrow Transplantation|January 1, 1991
Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMAS Suciu, G Solbu, R Zittoun, et al.
Pageof 30

Showing results (91-100 of 299) with videos related to

Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's diseaseM Tubiana, M Henry-Amar, M V Burgers, et al.
Nouvelle Revue Francaise D'Hematologie; Blood Cells|January 1, 1977
[Treatment of clinical stages I and II of Hodgkin's disease]M Tubiana, G Mathé, M Hayat, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
The contribution of clinical trials to the treatment of patients with early stages of Hodgkin's diseaseM Tubiana, J M Cosset, P Carde, et al.
Blood|August 15, 1994
Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?P Y Dietrich, M Henry-Amar, J M Cosset, et al.
Bulletin Du Cancer|January 1, 1989
[Intracranial localization of Hodgkin's disease. Apropos of 2 cases]J P Constans, A Castresana, J F Meder, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1985
Erythropoietic recovery in human after extended field radiotherapy. Ferrokinetic studies of patients treated by radiotherapy followed by autologous bone marrow transplantation and of patients treated by moderate doses (20 Gy) of radiotherapyC Parmentier, N Morardet, M Schlumberger, et al.
Annales De Medecine Interne|February 1, 1975
[10 years of immunotherapy of leukemia and cancers]G Mathe, L Schwarzenberg, J L Amiel, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|November 7, 1977
[Oncostatic activity of extracts from Alangium vitiense on murine lymphoid neoplasms]M Hayat, G Mathé, E Chenu, et al.
Cancer Research|May 1, 1978
Oncostatic effects of Alangium vitiense extracts (ICIG-EORTC 1131, 1186 and 1207) on lymphoid murine tumorsG Mathé, M Hayat, E Chenu, et al.
Bone Marrow Transplantation|January 1, 1991
Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMAS Suciu, G Solbu, R Zittoun, et al.
Pageof 30